Sunday 11 October 2026 Export all NVO data to Excel Powerpack

Novo Nordisk A/S

NVO Healthcare Drug Manufacturers General

Novo Nordisk A/S’s revenue for fiscal 2025 (year ended December 2025) was $46.8 billion, up 11.1% from fiscal 2024. In the quarter to June 2026, revenue grew 4.47%, EPS fell 18.7%, free cash flow grew 71.6% and total debt rose 44.4%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for five.

38.64 0.46 +1.20%

Follow NVO

Alert me

Market cap: $127.8B
P/E: 9.4×
Fwd P/E: —
Dividend yield: 4.65%
F-score: 5/9
Altman Z: 4.32
Beneish M: −2.51
Dividend safety: 46/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	16.13	14.66	8.63	11.72
P/S ratio Full definition →		5.28	4.83	3.20	4.13
P/FCF ratio Full definition →		26.20	51.51	33.56	27.94
P/Operating CF Full definition →		32.83	393.97	43.28	24.83
P/B ratio Full definition →		9.27	7.69	5.13	6.18
Price to Tangible BV Full definition →		24.88	23.33	14.25	13.77
EV/Sales Full definition →		5.48	5.15	3.58	4.41
EV/EBITDA Full definition →		11.22	10.63	6.86	8.57
EV/Operating CF Full definition →		13.49	13.35	9.93	11.11
EV/FCF Full definition →		27.18	54.86	37.45	29.81
Quick Ratio Full definition →		0.57	0.57	0.56	0.66
Current Ratio Full definition →		0.78	0.80	0.79	0.87
Net Debt/EBITDA Full definition →		1.87	2.53	1.91	2.44
Debt/Assets Full definition →		19.76%	24.12%	26.18%	23.55%
Debt/Equity Full definition →		0.60	0.67	0.72	0.63
Asset Turnover Full definition →		0.67	0.63	0.65	0.62
Operating CF/Net income Full definition →		2.40	0.14	0.50	2.62
Capex/Depreciation Full definition →		(2.04)	(8.45)	(3.40)	(1.24)
Interest Coverage Full definition →		(15.50)	(22.99)	17.04	18.04
Research and Development Expense of Revenue Full definition →		20.53%	18.11%	10.62%	22.66%
Selling, General and Administrative Expense of Revenue Full definition →		23.85%	21.87%	13.65%	20.78%
Intangible Assets out of Total Assets Full definition →		0.21	0.24	0.23	0.21
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Graham Net Nets Full definition →		(0.10)	(0.12)	(0.17)	(0.12)
Graham Number Full definition →		21.52	22.72	26.20	26.73
Earnings Yield Full definition →		6.20%	6.82%	11.59%	8.53%
Free Cash Flow Yield Full definition →		3.82%	1.94%	2.98%	3.58%
Revenue per Share Full definition →		2.64	2.78	3.41	2.75
Operating CF per Share Full definition →		1.69	0.13	0.85	1.93
Capex per Share Full definition →		(0.57)	(1.44)	(0.42)	(0.45)
Free Cash Flow per Share Full definition →		1.12	(1.31)	0.42	1.48
Cash per Share Full definition →		1.48	1.15	0.91	1.71
Shareholders Equity per Share Full definition →		5.98	6.61	7.16	7.76
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		5.98	6.61	7.16	7.76
Free Cash Flow Full definition →		4,961.69	(5,822.49)	1,886.25	6,585.08
Working Capital Full definition →		(8,217.58)	(6,541.70)	(7,491.90)	(4,728.22)
Capital Expenditures Full definition →		(2,552.86)	(6,396.29)	(1,885.31)	(1,979.80)
Net Current Asset Value Full definition →		(25,135.71)	(26,707.27)	(28,006.19)	(25,669.02)
EV/EBIT Full definition →		13.12	12.46	7.85	10.17
Capex to Sales Full definition →		0.22	0.52	0.12	0.16
Price to Operating Income Full definition →		12.64	11.70	7.04	9.53
Other line items
Average Receivables Full definition →		13,101.46	13,088.90	13,944.11	14,970.60
Average Payables Full definition →		3,646.31	3,587.02	2,540.16	3,280.25
Average Inventory Full definition →		6,516.04	6,718.01	7,044.14	7,467.02
Average Assets Full definition →		69,403.55	74,867.82	78,297.39	82,954.15
Average Common Equity Full definition →		22,185.33	25,092.09	25,673.99	29,996.77

Show all line items

Columns are period end dates

Stockrow Weekly